A5017433798- Esophageal and GI Pathology
- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Surgical Treatments
- Metastasis and carcinoma case studies
- Pancreatic and Hepatic Oncology Research
- Anorectal Disease Treatments and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Lung Cancer Diagnosis and Treatment
- COVID-19 and healthcare impacts
- Gastroesophageal reflux and treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Neurofibromatosis and Schwannoma Cases
- Congenital Diaphragmatic Hernia Studies
- Diverticular Disease and Complications
- Dysphagia Assessment and Management
- Enhanced Recovery After Surgery
- Appendicitis Diagnosis and Management
- Dermatologic Treatments and Research
- Aortic aneurysm repair treatments
- Sarcoma Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Eosinophilic Esophagitis
- Testicular diseases and treatments
- Pelvic and Acetabular Injuries
University of Milan
2023-2025
Istituto Ortopedico Galeazzi
2023-2025
Ospedale Maggiore
2024
Istituto Clinico Sant'Ambrogio
2024
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2023
Yahoo (United Kingdom)
2023
Azienda Socio Sanitaria Territoriale di Bergamo Ovest
2021-2022
Azienda Ospedaliera Treviglio
2021-2022
European Institute of Oncology
2022
Sapienza University of Rome
2022
Minimally invasive surgery for the treatment of locally advanced gastric cancer (AGC) is debated. The aim this study was to execute a comprehensive assessment principal surgical treatments resectable distal cancer.
Background: Thoracic duct ligation (TDL) during esophagectomy has been proposed to reduce the risk of postoperative chylothorax. Because its role in immunoregulation, some authors argued that it had an unfavorable TDL effect on survival. The aim this study was analyze overall survival (OS). Methods: PubMed, MEDLINE, Scopus, and Web Science were searched through December 2023. primary outcome 5-year OS. restricted mean time difference (RMSTD), hazard ratios (HRs), 95% confidence intervals...
Severe postoperative complications (SPCs) may occur after curative esophagectomy for cancer and are associated with prolonged hospital stay, augmented costs, increased in-hospital mortality. However, the effect of SPCs on survival is uncertain. To assess impact severe long-term following cancer, we conducted a systematic search PubMed, MEDLINE, Scopus, Web Science databases up to December 2023. The included studies examined relationship between outcomes, defining as Clavien-Dindo grade > 3....
Background: Ischemia at the anastomotic site is a critical protagonist in development of anastomosis-related complications after esophagectomy. Gastric ischemic conditioning (GIC) before esophagectomy has been described to improve vascular perfusion tip gastric conduit with potential effect on leak (AL) and stenosis (AS) risk minimization. Laparoscopic (LapGIC) angioembolization (AngioGIC) techniques have reported. Purpose: Compare short-term outcomes among different GIC techniques. Methods:...
Background: Esophageal perforation is a heterogeneous clinical entity. The common denominator mediastinal contamination by digestive contents possibly evolving to sepsis, multiorgan failure, and death if not timely appropriately treated. Mortality ranges between 10% 20% while delay in treatment (>24 hours) has been shown be valuable inverse survival predictor. Non-operative management (NOM) endoscopic may considered stable patients with early presentation, limited esophageal disruption,...